dna: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Other	0	-
Net cash provided by (used in) financing activities	9,633	-305
Effect of foreign exchange rates on cash and cash equivalents	353	260
Net decrease in cash, cash equivalents and restricted cash	-448,783	-354,392
Cash and cash equivalents at beginning of period	605,743	-
Cash and cash equivalents at end of period	156,960	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Other	0	-
Net cash provided by (used in) financing activities	9,633	-305
Effect of foreign exchange rates on cash and cash equivalents	353	260
Net decrease in cash, cash equivalents and restricted cash	-448,783	-354,392
Cash and cash equivalents at beginning of period	605,743	-
Cash and cash equivalents at end of period	156,960	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)